The Luxembourg BioHealth Cluster managed by Luxinnovation aims to strengthen and capitalise on the national strategy developed by Luxembourg’s government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine.

Its members are R&D companies, public research organisations, laboratories, hospitals and other actors (patients associations, service and capital providers, etc.) whose activities are related to health sciences and technologies.

The main focus of the Cluster is personalised medicine, an area in which Luxembourg has identified niche areas of expertise where the country has strong potential to be competitive at a global level: digital health, neurodegenerative diseases, molecular diagnostics and immune-oncology.

Objectives:

  • reinforcing and capitalising on Luxembourg’s national strategy to achieve scientific excellence in molecular diagnostics
  • enhance Luxembourg’s reputation as a recognised and attractive environment for biomedical research, development, innovation (RDI) and business.
  • support the community, help members find new opportunities for advancement here in Luxembourg and abroad, and work with them to articulate their needs and their challenges at a national level.
Luxembourg BioHealth Cluster

Members list

company / private organisation

MEMBERS CATALOGUE

Did you know...

Stay up to date

Latest news

LIAB Award 2017: A molecule that fights cancer

27-11-2017

Paul Spagnuolo, a world leader in nutraceutical research, and his discovery of an avocado-based lipid that attacks leukaemia stem cells are the winners of LIST’s first International Award in Bioinnovation (LIAB Award 2017).
Read more

IBBL participates in €34 million EU project on liver disease

23-11-2017

IBBL (Integrated BioBank of Luxembourg) is the central biobank for a pioneering EU project that aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) a...
Read more

The anti-cancer potential of the avocado highlighted by LIST

16-11-2017

Paul Spagnuolo, a world leader in bioinnovation research, will be honoured for his work on an avocado-derived lipid with potent antileukemia activity with the first LIST International Award in Bioinno...
Read more

In search of the best drug

09-11-2017

Prof. Ines Thiele, researcher at the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg has been selected for the highly prestigious research funding of the European Research Council (ERC).
Read more

All news

  • Monday
  • Tuesday
  • Wednesday
  • Thursday
  • Friday
  • Saturday
  • Sunday

Meet us

Upcoming events

No events

Other clusters in Luxembourg

Menu
Fermer